查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1756515

全球診斷心電圖/ECG 市場（按產品、導線類型、類型、部署/連接、最終用戶和地區分類）- 預測至 2032 年

Diagnostic Electrocardiograph/ECG Market by Product (Resting ECG, Stress ECG, Mobile Cardiac Telemetry), Lead Type (Single-lead, 3, 5, 6 & 12-lead ECG Device), Type (Portable ECG Device, Wearable ECG Device), Connectivity - Global Forecast to 2032
出版日期: | 出版商: MarketsandMarkets | 英文 374 Pages | 訂單完成後即時交付

價格

全球診斷心電圖/ECG市場規模預計將從 2025 年的 91.9 億美元成長到 2032 年的 151.8 億美元，預測期內的複合年成長率為 7.4%。

研究範圍
調查年份 2024-2032
基準年 2024
預測期 2024-2032
對價單位 金額（十億美元）
部分 按產品、按線索類型、按類型、按部署/連接、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

全球老年人口的大幅成長，加上糖尿病和心血管疾病（CVD）等慢性疾病盛行率的上升，預計將推動診斷性心電圖市場的需求。此外，對預防性醫療保健的日益重視、醫療支出的不斷成長以及各地區醫療基礎設施的不斷改善，也將推動市場成長。診斷性心電圖設備的技術進步、創新產品的推出、優惠的報銷框架以及政府的支持性政策預計將進一步增強市場活力。醫療基礎設施的投資以及提高診斷性心電圖解決方案的可用性和可負擔性的努力，也有望推動市場擴張。

診斷性心電圖市場主要由設備驅動，設備在 2024 年佔據了最大的市場佔有率。這一快速成長的主要驅動力是冠狀動脈疾病、中風和周邊動脈疾病等心血管疾病發病率的上升。此外，老年族群對早期和持續心臟監測的需求以及遠端患者管理的日益成長趨勢顯著推動了這一成長趨勢。設備技術的最新進展，例如小型化和增強的無線連接，正在使這些設備更有效率、以使用者為中心且易於使用。這項發展將使心臟護理能夠在傳統的臨床環境和偏遠地區進行，從而改善患者的治療效果並最佳化醫療服務。

根據導極類型，診斷性心電圖市場分為 12 導程、5 導程、3 導程、6 導程和單導程聯心電圖設備。 12 導程心電圖系統佔據市場主導地位，因為它們透過 12 個電極放置提供對心臟電活動的全面分析和多方面視圖。此功能有助於準確診斷各種心血管疾病，包括心肌梗塞、複雜心律不整和缺血性心臟疾病。臨床醫生，尤其是急診室、ICU 和專科心臟病診所的臨床醫生，嚴重依賴 12 導程心電圖提供的豐富數據來做出關鍵的臨床決策和及時的治療性介入。此外，最近的技術進步，如具有無線連接和與遠端醫療平台無縫整合的可攜式數位 12 導聯心電圖設備，進一步鞏固了這些系統在診斷性心電圖領域的關鍵作用。

根據部署/連接，診斷心電圖市場細分為獨立式、基於 PC 和雲端基礎的心電圖設備。獨立心電圖設備佔據了市場佔有率，這得益於全球心血管疾病 (CVD) 盛行率的上升，這些疾病需要更容易存取和持續的監測。技術的進步，加上對遠端患者監護和居家醫療的日益關注，導致了小型、高精度和易於使用的設備的發展。這一趨勢也增強了預防性保健，並有助於在傳統臨床環境之外自我監測心臟健康。這些設備有助於早期發現心律不整和其他心臟疾病，從而減少就診頻率。這些設備是預防性心臟健康管理的經濟有效的選擇，並且可以與遠端醫療平台和人工智慧無縫整合，以增強診斷能力。

全球診斷心電圖市場分為五個地區：北美、歐洲、亞太、拉丁美洲以及中東和非洲。北美是診斷心電圖最大的區域市場，而亞太市場預計在預測期內將以最高的複合年成長率成長。

北美市場佔據主導地位主要得益於幾個相互關聯的因素。首先，心血管疾病（CVD）的盛行率不斷上升，已成為一個緊迫的公共衛生問題，從而增加了對相關醫療服務和產品的需求。此外，北美健全且完善的醫療基礎設施也進一步支撐了這一成長，這些基礎設施能夠有效地提供醫療服務和資源，以應對這些健康挑戰。此外，北美人擁有較高的可支配收入，這使得他們能夠優先考慮與健康相關的投資，例如預防保健和先進的治療方案。這種經濟實力也推動了創新醫療技術和解決方案的採用，這些技術和解決方案在該地區已廣泛普及。醫療保健領域最尖端科技的廣泛應用，包括診斷工具、治療方法和患者管理系統，提高了整體護理質量，並改善了心血管疾病患者的健康狀況。這些因素共同為北美市場的成長和醫療保健解決方案的持續發展創造了良好的環境。此外，通用電氣醫療集團（GE Healthcare）、百特（Baxter）和OSI系統公司等業界領先公司的影響力預計將推動該地區診斷心電圖市場的成長。

本報告研究了全球診斷心電圖/ECG市場，並提供了有關市場的詳細資訊，包括產品、導線類型、類型、部署/連接、最終用戶、區域趨勢和公司簡介。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章重要考察

第5章市場概述

  • 介紹
  • 市場動態
  • 產業趨勢
  • 技術分析
  • 波特五力分析
  • 監管狀況
  • 專利分析
  • 貿易分析
  • 定價分析
  • 贖回方案
  • 2025-2026 年重要會議與活動
  • 主要相關人員和採購標準
  • 未滿足的需求/最終用戶期望
  • 價值鏈分析
  • 供應鏈分析
  • 生態系分析
  • 人工智慧/產生人工智慧對診斷心電圖市場的影響
  • 案例研究分析
  • 影響客戶業務的趨勢/中斷
  • 2025年美國關稅的影響
  • 投資金籌措場景

第6章 診斷心電圖儀/心電圖市場（依產品）

  • 介紹
  • 裝置
  • 軟體和服務

7. 診斷心電圖儀/心電圖市場（依導線類型）

  • 介紹
  • 12條線索
  • 5條線索
  • 3條線索
  • 6 領先
  • 單導程
  • 其他

第 8 章 診斷心電圖儀/心電圖市場（按類型）

  • 介紹
  • 可攜式的
  • 穿戴式裝置
  • 嵌入式

第9章 診斷心電圖儀/心電圖市場（依部署/連接）

  • 介紹
  • 獨立心電圖儀
  • 基於PC的心電圖儀
  • 雲端基礎的心電圖

第 10 章 診斷心電圖儀/心電圖市場（依最終用戶）

  • 介紹
  • 醫院
  • 基層醫療中心
  • 心臟中心
  • 門診手術中心
  • 居家照護
  • 急診室
  • 其他

第 11 章 診斷心電圖儀/心電圖市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 馬來西亞
    • 泰國
    • 印尼
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 海灣合作理事會國家
    • 其他

第12章競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 收益佔有率分析（2022-2024）
  • 2024年市場佔有率分析
  • 公司估值矩陣：2024 年主要參與企業
  • 2024 年初Start-Ups/中小企業估值矩陣
  • 品牌/產品比較
  • 診斷心電圖市場：公司估值與財務指標
  • 競爭場景

第13章 公司簡介

  • 主要參與企業
    • KONINKLIJKE PHILIPS NV
    • GE HEALTHCARE
    • MEDTRONIC
    • BOSTON SCIENTIFIC CORPORATION
    • ABBOTT LABORATORIES
    • BAXTER（HILL-ROM HOLDINGS, INC.）
    • FUKUDA DENSHI
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • NIHON KOHDEN CORPORATION
    • OSI SYSTEMS, INC.
    • BITTIUM
    • IRHYTHM TECHNOLOGIES, INC.
    • LEPU MEDICAL TECHNOLOGY（BEIJING）CO., LTD.
    • MIDMARK CORPORATION
    • BPL MEDICAL TECHNOLOGIES
    • SCHILLER
    • ACS DIAGNOSTICS
    • ALLENGERS
    • BIONET CO., LTD.
  • 其他公司
    • EDAN INSTRUMENTS, INC.
    • QINGDAO MEDITECH EQUIPMENT CO., LTD.
    • CARDIAC INSIGHT, INC.
    • ALIVECOR, INC.
    • VITALCONNECT
    • BTL
    • BORSAM MEDICAL
    • NASIFF ASSOCIATES, INC.
    • VECTRACOR, INC.
    • BIOMEDICAL INSTRUMENTS CO., LTD.
    • LIFESIGNALS

第14章 附錄

Product Code: MD 2551

The global diagnostic electrocardiograph/ECG market is projected to reach USD 15.18 billion by 2032 from USD 9.19 billion in 2025, at a CAGR of 7.4% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2032
Base Year2024
Forecast Period2024-2032
Units ConsideredValue (USD billion)
SegmentsProduct, lead type, type, deployment/ connectivity, end user, and region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

The significant expansion of the geriatric demographic worldwide, coupled with the escalating prevalence of chronic conditions such as diabetes and CVDs, is poised to drive the demand for the diagnostic ECG market. Additionally, the increasing focus on preventive healthcare, coupled with rising healthcare expenditures and improvements in healthcare infrastructure across various regions, also facilitates market growth. Technological advancements in diagnostic ECG devices, the introduction of innovative products, and favorable reimbursement frameworks, along with supportive government policies, are further expected to enhance market dynamics. Investments in healthcare infrastructure and initiatives to improve the accessibility and affordability of diagnostic ECG solutions are also likely to bolster market progression.

The diagnostic ECG devices segment is to grow at the highest CAGR during the forecast period.

The diagnostic ECG market is predominantly driven by devices, which command the largest market share in 2024. This surge is primarily attributed to the rising incidence of CVDs, including coronary artery disease, stroke, and peripheral artery disease. Furthermore, the demand for early and continuous cardiac monitoring among geriatric populations, along with the increasing trend toward remote patient management, significantly underpins this growth trajectory. Recent advancements in device technology, such as miniaturization and enhanced wireless connectivity, are rendering these instruments more efficient, user-centric, and accessible. This evolution enables the provision of cardiac care in both conventional clinical environments and remote settings, thereby improving patient outcomes and optimizing healthcare delivery.

The 12-lead ECG devices segment captured the largest market share, by lead type, in 2024.

Based on lead type, the diagnostic ECG market is segmented into 12, 5, 3, 6, and single lead ECG devices. The 12-lead ECG systems dominate the market due to their ability to deliver comprehensive analysis and a multi-faceted view of cardiac electrical activity through twelve electrode placements-this capability facilitates accurate diagnosis of a range of CVDs, including myocardial infarctions, complex arrhythmias, and ischemic heart disease. Clinicians, particularly in emergency departments, ICUs, and specialized cardiology clinics, heavily depend on the rich data provided by 12-lead ECGs for critical clinical decision-making and timely therapeutic interventions. Furthermore, recent technological advancements, such as portable digital 12-lead ECG devices featuring wireless connectivity and seamless integration with telemedicine platforms, have further solidified the essential role of these systems in the landscape of diagnostic ECG.

The standalone ECG devices segment commanded the largest market share, by deployment/connectivity in 2024.

Based on deployment/ connectivity, the diagnostic ECG market is segmented into standalone, PC-based, and cloud-based ECG devices. Standalone ECG devices accounted for the market share, driven by the rising global prevalence of CVDs that necessitate more accessible and continuous monitoring. The technological advancements have led to the development of compact, precise, and user-friendly devices, coupled with an increasing focus on remote patient monitoring and home-based care. This trend also enhances preventive health management and facilitates self-monitoring of cardiac health outside traditional clinical environments. These devices are instrumental in the early detection of arrhythmias and other cardiac conditions, thus reducing the frequency of hospital visits. They serve as cost-effective alternatives for proactive cardiac health management and can be seamlessly integrated with telemedicine platforms and artificial intelligence for enhanced diagnostic capabilities.

North America accounted for the largest regional share of the diagnostic ECG market in 2024.

The global diagnostic ECG market is segmented into five major regions: North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for diagnostic ECG, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

The significant predominance of the North American market can largely be attributed to several interrelated factors. Firstly, there is a rising incidence of CVDs, which has become a pressing public health concern and is driving demand for related healthcare services and products. This increase is further supported by a robust and well-established healthcare infrastructure that efficiently provides medical care and resources to address these health challenges. Additionally, the population in North America enjoys elevated disposable incomes, which allows individuals to prioritize spending on health-related investments, including preventive care and advanced treatment options. This financial capability also supports the adoption of innovative medical technologies and solutions, which are widely accessible throughout the region. The extensive availability of cutting-edge technological advancements in healthcare, including diagnostic tools, treatment modalities, and patient management systems, enhances the overall quality of care and improves health outcomes for patients with CVDs. Together, these factors create a strong environment for market growth and the ongoing evolution of healthcare solutions in North America. Furthermore, the influence of leading industry players such as GE Healthcare, Baxter, and OSI Systems, Inc. is expected to catalyze growth in the diagnostic ECG market within the region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3- 25%
  • By Designation: C-level-30%, Director-level-23%, and Other Designations-47%
  • By Region: North America-35%, Europe-20%, Asia Pacific-25%, Latin America-13%, and Middle East & Africa-7%

The major players operating in the diagnostic ECG market are GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Baxter (US), FUKUDA DENSHI (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), NIHON KOHDEN CORPORATION (Japan), OSI Systems, Inc. (US), Bittium (Finland), iRhythm Technologies, Inc. (US), Lepu Medical Technology (Beijing) Co., Ltd. (China), Midmark Corporation (US), BPL Medical Technologies (India), SCHILLER (Switzerland), ACS Diagnostics (US), Allengers (India), and Bionet Co., Ltd. (South Korea).

Research Coverage

This report studies the diagnostic ECG market based on product, lead type, type, deployment/ connectivity, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.

This report provides insights on the following points:

  • Analysis of Key divers (increasing incidence of lifestyle and cardiovascular diseases, expanding global geriatric population and subsequent surge in heart conditions, development of wireless monitoring and wearable cardiac devices, and growing need for cost-containment across healthcare facilities), restraints (stringent regulatory requirements delaying cardiac device approval and technological limitations of diagnostic ECG devices & software), Opportunities (High growth opportunities in emerging economies and expanding access to advanced cardiac diagnostics with AI and CMS support), Challenges (Limited integration of ECG Systems with electronic health records and accuracy challenges in next-generation ECG monitoring)
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the diagnostic ECG market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the diagnostic ECG market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the diagnostic ECG market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION OF DIAGNOSTIC ECG PRODUCTS
    • 2.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)
    • 2.2.2 MNM REPOSITORY ANALYSIS
    • 2.2.3 COMPANY INVESTOR PRESENTATIONS AND PRIMARY INTERVIEWS
    • 2.2.4 TOP-DOWN APPROACH
    • 2.2.5 BOTTOM-UP APPROACH
    • 2.2.6 PRIMARY INTERVIEWS
    • 2.2.7 DEMAND-SIDE APPROACH
    • 2.2.8 VOLUME DATA ANALYSIS
  • 2.3 MARKET GROWTH RATE PROJECTION
  • 2.4 DATA TRIANGULATION
    • 2.4.1 STUDY ASSUMPTIONS
    • 2.4.2 RESEARCH LIMITATIONS
  • 2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 DIAGNOSTIC ECG MARKET OVERVIEW
  • 4.2 NORTH AMERICA: DIAGNOSTIC ECG MARKET SHARE, BY TYPE AND COUNTRY (2024)
  • 4.3 DIAGNOSTIC ECG DEVICES MARKET SHARE, BY DEVICE TYPE, 2025 VS. 2032
  • 4.4 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2025 VS. 2032 (USD MILLION)
  • 4.5 DIAGNOSTIC ECG MARKET, BY END USER, 2025 VS. 2032 (USD MILLION)
  • 4.6 DIAGNOSTIC ECG MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of lifestyle and cardiovascular diseases
      • 5.2.1.2 Rapidly expanding global geriatric population and subsequent surge in heart conditions
      • 5.2.1.3 Development of wireless monitoring and wearable cardiac devices
      • 5.2.1.4 Growing need for cost-containment across healthcare facilities
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Stringent regulatory requirements delaying approval of cardiac devices
      • 5.2.2.2 Technological limitations of diagnostic ECG devices and software
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets to offer high-growth opportunities
      • 5.2.3.2 Expanding access to advanced cardiac diagnostics with AI and CMS support
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Challenges in integrating ECG systems with Electronic Health Records (EHRs)
      • 5.2.4.2 Accuracy challenges in next-generation ECG monitoring
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 MINIATURIZATION AND WEARABLE ECG DEVICES
    • 5.3.2 REMOTE AND HOME-BASED DIAGNOSTICS
    • 5.3.3 HIGH-FIDELITY AND MULTI-LEAD PORTABLE ECGS
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Wearable devices and sensors
      • 5.4.1.2 Integration of Artificial Intelligence (AI)
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Wireless ECG devices
      • 5.4.2.2 Mobile apps integration
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Vital sign monitors
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 THREAT OF NEW ENTRANTS
    • 5.5.2 THREAT OF SUBSTITUTES
    • 5.5.3 BARGAINING POWER OF BUYERS
    • 5.5.4 BARGAINING POWER OF SUPPLIERS
    • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.6 REGULATORY LANDSCAPE
    • 5.6.1 REGULATORY ANALYSIS
    • 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.6.3 REGULATORY FRAMEWORK
      • 5.6.3.1 North America
        • 5.6.3.1.1 US
        • 5.6.3.1.2 Canada
      • 5.6.3.2 Europe
      • 5.6.3.3 Asia Pacific
        • 5.6.3.3.1 China
        • 5.6.3.3.2 Japan
        • 5.6.3.3.3 India
      • 5.6.3.4 Latin America
        • 5.6.3.4.1 Brazil
        • 5.6.3.4.2 Mexico
      • 5.6.3.5 Middle East
      • 5.6.3.6 Africa
  • 5.7 PATENT ANALYSIS
    • 5.7.1 PATENT PUBLICATION TRENDS FOR DIAGNOSTIC ECG
    • 5.7.2 JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.8 TRADE ANALYSIS
    • 5.8.1 TRADE ANALYSIS FOR DIAGNOSTIC ECG PRODUCTS
    • 5.8.2 TRADE DATA FOR HS CODE 901811
      • 5.8.2.1 Import data for HS Code 901811
      • 5.8.2.2 Export data for HS Code 901811
  • 5.9 PRICING ANALYSIS
    • 5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER
      • 5.9.1.1 Average selling price of resting ECG, by key player
      • 5.9.1.2 Average selling price for stress ECG, by key player
      • 5.9.1.3 Average selling price of Holter monitors, by key player
    • 5.9.2 AVERAGE SELLING PRICE, BY REGION
      • 5.9.2.1 Average selling price of resting ECG, stress ECG, and Holter monitors, by region
  • 5.10 REIMBURSEMENT SCENARIO
  • 5.11 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.12.2 KEY BUYING CRITERIA
  • 5.13 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.14 VALUE CHAIN ANALYSIS
  • 5.15 SUPPLY CHAIN ANALYSIS
  • 5.16 ECOSYSTEM ANALYSIS
  • 5.17 IMPACT OF AI/GEN AI ON DIAGNOSTIC ECG MARKET
    • 5.17.1 INTRODUCTION
    • 5.17.2 MARKET POTENTIAL IN DIAGNOSTIC ECG ECOSYSTEM
    • 5.17.3 AI USE CASES
    • 5.17.4 KEY COMPANIES IMPLEMENTING AI IN DIAGNOSTIC ECG DEVICES
    • 5.17.5 FUTURE OF GEN AI IN DIAGNOSTIC ECG ECOSYSTEM
  • 5.18 CASE STUDY ANALYSIS
  • 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.20 IMPACT OF 2025 US TARIFF
    • 5.20.1 INTRODUCTION
    • 5.20.2 KEY TARIFF RATES
    • 5.20.3 PRICE IMPACT ANALYSIS
    • 5.20.4 IMPACT ON COUNTRY/REGION
    • 5.20.5 IMPACT ON END-USER INDUSTRIES
  • 5.21 INVESTMENT AND FUNDING SCENARIO

6 DIAGNOSTIC ECG MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 DEVICES
    • 6.2.1 RESTING ECG DEVICES
      • 6.2.1.1 Wide availability of resting ECG devices to support market growth
    • 6.2.2 STRESS ECG DEVICES
      • 6.2.2.1 High cost of stress ECG devices to limit adoption
    • 6.2.3 HOLTER MONITORS
      • 6.2.3.1 Growing demand for continuous monitoring to fuel growth
    • 6.2.4 EVENT MONITORS
      • 6.2.4.1 Increasing outsourcing of monitoring devices to propel market growth
    • 6.2.5 IMPLANTABLE LOOP RECORDERS
      • 6.2.5.1 Introduction of technologically advanced implantable loop recorders to support market growth
    • 6.2.6 MOBILE CARDIAC TELEMETRY DEVICES
      • 6.2.6.1 Increasing demand for cardiac monitoring solutions in home care settings to propel market
    • 6.2.7 SMART ECG MONITORS
      • 6.2.7.1 Rising adoption of smart/wearable ECG monitors
  • 6.3 SOFTWARE & SERVICES
    • 6.3.1 SHIFT TOWARD AI-ENABLED ECG SOFTWARE TO SUPPORT GROWTH

7 DIAGNOSTIC ECG MARKET, BY LEAD TYPE

  • 7.1 INTRODUCTION
  • 7.2 12-LEAD ECG DEVICES
    • 7.2.1 GROWING USE IN PRE-HOSPITAL AND CLINIC SETTINGS TO DRIVE MARKET GROWTH
  • 7.3 5-LEAD ECG DEVICES
    • 7.3.1 GROWING IMPORTANCE OF PATIENT MONITORING TO BOOST ADOPTION
  • 7.4 3-LEAD ECG DEVICES
    • 7.4.1 VITAL TOOL FOR RHYTHM MONITORING TO SUPPORT MARKET GROWTH
  • 7.5 6-LEAD ECG DEVICES
    • 7.5.1 GROWING USE OF 6-LEAD ECG DEVICES IN REMOTE PATIENT MONITORING TO FAVOR MARKET GROWTH
  • 7.6 SINGLE-LEAD ECG DEVICES
    • 7.6.1 EASE OF USE FOR DIAGNOSIS AND QUICK RESULTS TO INCREASE USE OF SINGLE-LEAD ECG DEVICES
  • 7.7 OTHER ECG LEAD DEVICES

8 DIAGNOSTIC ECG MARKET, BY TYPE

  • 8.1 INTRODUCTION
  • 8.2 PORTABLE 138 8.2.1 CONVENIENCE AND ACCESSIBILITY OF PORTABLE ECG DEVICES TO ENHANCE EARLY CARDIAC SCREENING
  • 8.3 WEARABLE
    • 8.3.1 RISING DEMAND FOR CONTINUOUS HEART MONITORING IN FITNESS AND CHRONIC DISEASE MANAGEMENT
  • 8.4 IMPLANTABLE 142 8.4.1 HIGH DIAGNOSTIC YIELD FOR ELUSIVE CARDIAC CONDITIONS WITH LONG-TERM MONITORING

9 DIAGNOSTIC ECG MARKET, BY DEPLOYMENT/CONNECTIVITY

  • 9.1 INTRODUCTION
  • 9.2 STANDALONE ECG DEVICES
    • 9.2.1 WIDESPREAD ADOPTION OF STANDALONE ECG DEVICES DUE TO OPERATIONAL SIMPLICITY
  • 9.3 PC-BASED ECG DEVICES
    • 9.3.1 GROWING USE FOR ADVANCED ECG DIAGNOSTICS AND INTEGRATION TO SUPPORT REMOTE CARDIAC CARE
  • 9.4 CLOUD-BASED ECG DEVICES
    • 9.4.1 ACCELERATED GROWTH OF CLOUD-BASED ECG SOLUTIONS TO SUPPORT REMOTE CARDIAC CARE

10 DIAGNOSTIC ECG MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS
    • 10.2.1 INCREASING UTILIZATION OF ECG DEVICES IN HOSPITALS TO ACCELERATE MARKET GROWTH
  • 10.3 PRIMARY CARE CENTERS
    • 10.3.1 WIDENING ACCESS TO ECG DIAGNOSTICS IN PRIMARY CARE CENTERS TO BOOST MARKET PENETRATION
  • 10.4 CARDIAC CENTERS
    • 10.4.1 SPECIALIZED ECG APPLICATIONS IN CARDIAC CENTERS TO DRIVE DEMAND FOR ADVANCED DEVICES
  • 10.5 AMBULATORY SURGICAL CENTERS
    • 10.5.1 GROWING NEED FOR PRE-OPERATIVE CARDIAC SCREENING IN ASCS TO INFLUENCE MARKET DEMAND
  • 10.6 HOME CARE SETTINGS
    • 10.6.1 RISING PREFERENCE FOR REMOTE MONITORING FUELS ECG DEVICE USAGE IN HOME CARE
  • 10.7 URGENT CARE SETTINGS
    • 10.7.1 INTEGRATION OF DIAGNOSTIC ECG IN URGENT CARE SETTINGS FOR TIMELY CARDIAC EVALUATIONS TO FUEL MARKET DEMAND
  • 10.8 OTHER END USERS
    • 10.8.1 DIVERSE ECG APPLICATIONS ACROSS NURSING HOMES, RETAIL CLINICS, SPORTS MEDICINE & RESEARCH TO INFLUENCE MARKET DEMAND

11 DIAGNOSTIC ECG MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 US to command largest share in diagnostic ECG market
    • 11.2.3 CANADA
      • 11.2.3.1 Growing adoption of digital diagnostic ECG systems to drive market growth
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 High healthcare spending to propel market growth
    • 11.3.3 FRANCE
      • 11.3.3.1 Government support for e-Health to propel market
    • 11.3.4 UK
      • 11.3.4.1 Rising demand for home-based smart ECG devices to support market growth
    • 11.3.5 ITALY
      • 11.3.5.1 Growing focus on improvements in patient care to drive market
    • 11.3.6 SPAIN
      • 11.3.6.1 Rising geriatric population to support market growth in Spain
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 JAPAN
      • 11.4.2.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan
    • 11.4.3 CHINA
      • 11.4.3.1 Government support for infrastructural improvement to drive market growth
    • 11.4.4 INDIA
      • 11.4.4.1 Increasing cardiac disease burden intensifies demand for ECG diagnostics
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 Increased patient volume and favorable government initiatives to drive market
    • 11.4.6 SOUTH KOREA
      • 11.4.6.1 Rising geriatric population to propel market growth
    • 11.4.7 MALAYSIA
      • 11.4.7.1 Increasing CVD burden and national digital health initiatives driving ECG adoption
    • 11.4.8 THAILAND
      • 11.4.8.1 National cardiac screening programs and smart hospital investments driving ECG adoption in Thailand
    • 11.4.9 INDONESIA
      • 11.4.9.1 Rising cardiac disease burden and public health digitalization efforts to drive ECG device uptake in Indonesia
    • 11.4.10 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Improving access to diagnostic services to drive growth
    • 11.5.3 MEXICO
      • 11.5.3.1 Rising heart disease to drive market growth
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 11.6.2 GCC COUNTRIES
      • 11.6.2.1 Kingdom of Saudi Arabia (KSA)
        • 11.6.2.1.1 Prevalence of CVDs boosting ECG adoption in Saudi Arabia
      • 11.6.2.2 United Arab Emirates (UAE)
        • 11.6.2.2.1 National CVD screening programs and digital health strategies driving market
      • 11.6.2.3 Rest of GCC Countries
    • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIAGNOSTIC ECG MARKET
  • 12.3 REVENUE SHARE ANALYSIS (2022-2024)
  • 12.4 MARKET SHARE ANALYSIS, 2024
    • 12.4.1 RANKING OF KEY PLAYERS
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY PRODUCT FOOTPRINT: KEY PLAYERS, 2024
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Region footprint
      • 12.5.5.3 Product footprint
      • 12.5.5.4 Lead type footprint
      • 12.5.5.5 Type footprint
      • 12.5.5.6 Deployment/Connectivity footprint
  • 12.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2024
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 12.6.5.1 Detailed list of key startups/SME players
      • 12.6.5.2 Competitive benchmarking of key startups/SME players
  • 12.7 BRAND/PRODUCT COMPARISON
  • 12.8 DIAGNOSTIC ECG MARKET: COMPANY VALUATION & FINANCIAL METRICS
    • 12.8.1 FINANCIAL METRICS
    • 12.8.2 COMPANY VALUATION
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES & APPROVALS
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS
    • 12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 KONINKLIJKE PHILIPS N.V.
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products/Services/Solutions offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product/Service launches
        • 13.1.1.3.2 Deals
        • 13.1.1.3.3 Other developments
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Key strengths/Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses and competitive threats
    • 13.1.2 GE HEALTHCARE
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Deals
        • 13.1.2.3.2 Other developments
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Key strengths/Right to win
        • 13.1.2.4.2 Strategic choice
        • 13.1.2.4.3 Weaknesses and competitive threats
    • 13.1.3 MEDTRONIC
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 MnM view
        • 13.1.3.3.1 Right to win
        • 13.1.3.3.2 Strategic choices
        • 13.1.3.3.3 Weaknesses and competitive threats
    • 13.1.4 BOSTON SCIENTIFIC CORPORATION
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 MnM view
        • 13.1.4.3.1 Right to win
        • 13.1.4.3.2 Strategic choices
        • 13.1.4.3.3 Weaknesses and competitive threats
    • 13.1.5 ABBOTT LABORATORIES
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Product launches
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Key strengths
        • 13.1.5.4.2 Strategic choices
        • 13.1.5.4.3 Weaknesses & competitive threats
    • 13.1.6 BAXTER (HILL-ROM HOLDINGS, INC.)
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
      • 13.1.6.3 MnM view
        • 13.1.6.3.1 Key strengths/Right to win
        • 13.1.6.3.2 Strategic choices
        • 13.1.6.3.3 Weaknesses & competitive threats
    • 13.1.7 FUKUDA DENSHI
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
      • 13.1.7.3 MnM view
        • 13.1.7.3.1 Key strengths
        • 13.1.7.3.2 Strategic choices
        • 13.1.7.3.3 Weaknesses & competitive threats
    • 13.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
      • 13.1.8.3 MnM view
        • 13.1.8.3.1 Key strengths
        • 13.1.8.3.2 Strategic choices
        • 13.1.8.3.3 Weaknesses & competitive threats
    • 13.1.9 NIHON KOHDEN CORPORATION
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
    • 13.1.10 OSI SYSTEMS, INC.
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
      • 13.1.10.3 Recent developments
        • 13.1.10.3.1 Expansions
    • 13.1.11 BITTIUM
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Deals
    • 13.1.12 IRHYTHM TECHNOLOGIES, INC.
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products offered
      • 13.1.12.3 Recent developments
        • 13.1.12.3.1 Product launches and approvals
        • 13.1.12.3.2 Deals
    • 13.1.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products offered
      • 13.1.13.3 Recent developments
        • 13.1.13.3.1 Product launches and approvals
        • 13.1.13.3.2 Other developments
    • 13.1.14 MIDMARK CORPORATION
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products offered
      • 13.1.14.3 Recent developments
        • 13.1.14.3.1 Product launches
    • 13.1.15 BPL MEDICAL TECHNOLOGIES
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products offered
      • 13.1.15.3 Recent developments
        • 13.1.15.3.1 Expansions
        • 13.1.15.3.2 Other developments
    • 13.1.16 SCHILLER
      • 13.1.16.1 Business overview
      • 13.1.16.2 Products offered
      • 13.1.16.3 Recent developments
        • 13.1.16.3.1 Product launches
        • 13.1.16.3.2 Other developments
    • 13.1.17 ACS DIAGNOSTICS
      • 13.1.17.1 Business overview
      • 13.1.17.2 Products offered
    • 13.1.18 ALLENGERS
      • 13.1.18.1 Business overview
      • 13.1.18.2 Products offered
    • 13.1.19 BIONET CO., LTD.
      • 13.1.19.1 Business overview
      • 13.1.19.2 Products offered
      • 13.1.19.3 Recent developments
        • 13.1.19.3.1 Other developments
  • 13.2 OTHER PLAYERS
    • 13.2.1 EDAN INSTRUMENTS, INC.
    • 13.2.2 QINGDAO MEDITECH EQUIPMENT CO., LTD.
    • 13.2.3 CARDIAC INSIGHT, INC.
    • 13.2.4 ALIVECOR, INC.
    • 13.2.5 VITALCONNECT
    • 13.2.6 BTL
    • 13.2.7 BORSAM MEDICAL
    • 13.2.8 NASIFF ASSOCIATES, INC.
    • 13.2.9 VECTRACOR, INC.
    • 13.2.10 BIOMEDICAL INSTRUMENTS CO., LTD.
    • 13.2.11 LIFESIGNALS

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 DIAGNOSTIC ECG MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 3 DIAGNOSTIC ECG MARKET: STUDY ASSUMPTIONS
  • TABLE 4 DIAGNOSTIC ECG MARKET: RISK ANALYSIS
  • TABLE 5 DIAGNOSTIC ECG MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 DIAGNOSTIC ECG MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023-2025
  • TABLE 12 IMPORT DATA FOR HS CODE 901811 (ELECTRO-CARDIOGRAPHS), BY COUNTRY, 2021-2024 (USD THOUSAND)
  • TABLE 13 EXPORT DATA FOR HS CODE 901811 (ELECTRO-CARDIOGRAPHS), BY COUNTRY, 2021-2024 (USD THOUSAND)
  • TABLE 14 AVERAGE SELLING PRICE TREND OF RESTING ECG, BY REGION, 2022-2024
  • TABLE 15 AVERAGE SELLING PRICE TREND OF STRESS ECG, BY REGION, 2022-2024
  • TABLE 16 AVERAGE SELLING PRICE TREND OF HOLTER MONITORS, BY REGION, 2022-2024
  • TABLE 17 COMMON CPT CODES AND AVERAGE REIMBURSEMENT RATES
  • TABLE 18 DIAGNOSTIC ECG MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
  • TABLE 20 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS
  • TABLE 21 DIAGNOSTIC ECG MARKET: CURRENT UNMET NEEDS
  • TABLE 22 DIAGNOSTIC ECG PROVIDERS: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 23 KEY COMPANIES IMPLEMENTING AI IN DIAGNOSTIC ECG DEVICES
  • TABLE 24 CASE STUDY 1: ARRHYTHMIA DETECTION IN SINGLE-LEAD ECG CHEST STRAP
  • TABLE 25 CASE STUDY 2: CARDIOSOFT ECG - BICESTER HEALTH CENTRE
  • TABLE 26 CASE STUDY 3: ENHANCING POST-STROKE ATRIAL FIBRILLATION DETECTION WITH PHILIPS BIOTEL HEART MCOT
  • TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 28 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR DIAGNOSTIC ELECTROCARDIOGRAPHS
  • TABLE 29 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
  • TABLE 30 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
  • TABLE 31 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
  • TABLE 32 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
  • TABLE 33 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 34 KEY PLAYERS PROVIDING DIAGNOSTIC ECG DEVICES
  • TABLE 35 DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 36 KEY PLAYERS PROVIDING RESTING ECG DEVICES
  • TABLE 37 RESTING ECG DEVICES MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 38 KEY PLAYERS PROVIDING STRESS ECG DEVICES
  • TABLE 39 STRESS ECG DEVICES MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 40 KEY PLAYERS PROVIDING HOLTER MONITORS
  • TABLE 41 HOLTER MONITORS MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 42 KEY PLAYERS PROVIDING EVENT MONITORS
  • TABLE 43 EVENT MONITORS MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 44 IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 45 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 46 SMART ECG MONITORS MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 47 DIAGNOSTIC ECG SOFTWARE & SERVICES MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 48 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 49 KEY PLAYERS PROVIDING 12-LEAD ECG DEVICES
  • TABLE 50 12-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 51 5-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 52 3-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 53 6-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 54 SINGLE-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 55 OTHER ECG LEAD DEVICES MARKET, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 56 DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 57 KEY PLAYERS PROVIDING PORTABLE ECG DEVICES
  • TABLE 58 DIAGNOSTIC ECG DEVICES MARKET FOR PORTABLE ECG DEVICES, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 59 KEY PLAYERS PROVIDING WEARABLE DIAGNOSTIC ECG DEVICES
  • TABLE 60 DIAGNOSTIC ECG DEVICES MARKET FOR WEARABLE ECG DEVICES, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 61 DIAGNOSTIC ECG DEVICES MARKET FOR IMPLANTABLE ECG DEVICES, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 62 DIAGNOSTIC ECG MARKET, BY DEPLOYMENT/CONNECTIVITY, 2023-2032 (USD MILLION)
  • TABLE 63 DIAGNOSTIC ECG DEVICES MARKET FOR STANDALONE ECG, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 64 DIAGNOSTIC ECG DEVICES MARKET FOR PC-BASED ECG DEVICES, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 65 DIAGNOSTIC ECG DEVICES MARKET FOR CLOUD-BASED ECG DEVICES, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 66 DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 67 DIAGNOSTIC ECG MARKET FOR HOSPITALS, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 68 DIAGNOSTIC ECG MARKET FOR PRIMARY CARE CENTERS, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 69 DIAGNOSTIC ECG MARKET FOR CARDIAC CENTERS, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 70 DIAGNOSTIC ECG MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 71 DIAGNOSTIC ECG MARKET FOR HOME CARE SETTINGS, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 72 DIAGNOSTIC ECG MARKET FOR URGENT CARE SETTINGS, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 73 DIAGNOSTIC ECG MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2023-2032 (USD MILLION)
  • TABLE 74 DIAGNOSTIC ECG MARKET, BY REGION, 2023-2032 (USD MILLION)
  • TABLE 75 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023-2032 (USD MILLION)
  • TABLE 76 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 77 NORTH AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 78 NORTH AMERICA: DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023-2032 (THOUSAND UNITS)
  • TABLE 79 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 80 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 81 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 82 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 83 US: KEY MACROINDICATORS
  • TABLE 84 US: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 85 US: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 86 US: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 87 US: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 88 US: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 89 US: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 90 CANADA: KEY MACROINDICATORS
  • TABLE 91 CANADA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 92 CANADA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 93 CANADA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 94 CANADA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 95 CANADA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 96 CANADA: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 97 EUROPE: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023-2032 (USD MILLION)
  • TABLE 98 EUROPE: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 99 EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 100 EUROPE: DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023-2032 (THOUSAND UNITS)
  • TABLE 101 EUROPE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 102 EUROPE: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 103 EUROPE: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 104 EUROPE: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 105 GERMANY: KEY MACROINDICATORS
  • TABLE 106 GERMANY: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 107 GERMANY: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 108 GERMANY: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 109 GERMANY: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 110 GERMANY: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 111 GERMANY: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 112 FRANCE: KEY MACROINDICATORS
  • TABLE 113 FRANCE: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 114 FRANCE: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 115 FRANCE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 116 FRANCE: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 117 FRANCE: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 118 FRANCE: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 119 UK: KEY MACROINDICATORS
  • TABLE 120 UK: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 121 UK: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 122 UK: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 123 UK: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 124 UK: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 125 UK: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 126 ITALY: KEY MACROINDICATORS
  • TABLE 127 ITALY: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 128 ITALY: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 129 ITALY: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 130 ITALY: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 131 ITALY: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 132 ITALY: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 133 SPAIN: KEY MACROINDICATORS
  • TABLE 134 SPAIN: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 135 SPAIN: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 136 SPAIN: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 137 SPAIN: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 138 SPAIN: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 139 SPAIN: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 140 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 141 REST OF EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 142 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 143 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 144 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 145 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023-2032 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023-2032 (THOUSAND UNITS)
  • TABLE 150 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 154 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 155 JAPAN: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 156 JAPAN: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 157 JAPAN: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 158 JAPAN: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 159 JAPAN: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 160 JAPAN: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 161 CHINA: MACROECONOMIC INDICATORS
  • TABLE 162 CHINA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 163 CHINA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 164 CHINA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 165 CHINA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 166 CHINA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 167 CHINA: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 168 INDIA: MACROECONOMIC INDICATORS
  • TABLE 169 INDIA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 170 INDIA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 171 INDIA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 172 INDIA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 173 INDIA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 174 INDIA: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 175 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 176 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 177 AUSTRALIA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 178 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 179 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 180 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 181 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 182 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 183 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 184 SOUTH KOREA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 185 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 186 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 187 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 188 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 189 MALAYSIA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 190 MALAYSIA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 191 MALAYSIA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 192 MALAYSIA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 193 MALAYSIA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 194 MALAYSIA: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 195 THAILAND: MACROECONOMIC INDICATORS
  • TABLE 196 THAILAND: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 197 THAILAND: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 198 THAILAND: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 199 THAILAND: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 200 THAILAND: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 201 THAILAND: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 202 INDONESIA: MACROECONOMIC INDICATORS
  • TABLE 203 INDONESIA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 204 INDONESIA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 205 INDONESIA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 206 INDONESIA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 207 INDONESIA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 208 INDONESIA: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 209 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 210 REST OF ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 211 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 212 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 213 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 214 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 215 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023-2032 (USD MILLION)
  • TABLE 216 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 217 LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 218 LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023-2032 (THOUSAND UNITS)
  • TABLE 219 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 220 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 221 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 222 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 223 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 224 BRAZIL: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 225 BRAZIL: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 226 BRAZIL: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 227 BRAZIL: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 228 BRAZIL: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 229 BRAZIL: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 230 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 231 MEXICO: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 232 MEXICO: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 233 MEXICO: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 234 MEXICO: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 235 MEXICO: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 236 MEXICO: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 237 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 238 REST OF LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 239 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 240 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 241 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 242 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 243 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023-2032 (USD MILLION)
  • TABLE 244 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 245 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 246 MIDDLE EAST AND AFRICA : DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023-2032 (THOUSAND UNITS)
  • TABLE 247 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 248 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 249 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 250 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 251 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023-2032 (USD MILLION)
  • TABLE 252 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 253 GCC COUNTRIES: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 254 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 255 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 256 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 257 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 258 KSA: KEY MACROINDICATORS
  • TABLE 259 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 260 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 261 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 262 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 263 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 264 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 265 UAE: KEY MACROINDICATORS
  • TABLE 266 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 267 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 268 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 269 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 270 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 271 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 272 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 273 REST OF GCC COUNTRIES: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 274 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 275 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 276 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 277 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 278 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023-2032 (USD MILLION)
  • TABLE 279 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023-2032 (USD MILLION)
  • TABLE 280 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023-2032 (USD MILLION)
  • TABLE 281 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023-2032 (USD MILLION)
  • TABLE 282 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023-2032 (USD MILLION)
  • TABLE 283 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY END USER, 2023-2032 (USD MILLION)
  • TABLE 284 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN DIAGNOSTIC ECG MARKET
  • TABLE 285 DIAGNOSTIC ECG MARKET: DEGREE OF COMPETITION, 2024
  • TABLE 286 DIAGNOSTIC ECG MARKET: REGION FOOTPRINT
  • TABLE 287 DIAGNOSTIC ECG MARKET: PRODUCT FOOTPRINT
  • TABLE 288 DIAGNOSTIC ECG MARKET: LEAD TYPE FOOTPRINT
  • TABLE 289 DIAGNOSTIC ECG MARKET: TYPE FOOTPRINT
  • TABLE 290 DIAGNOSTIC ECG MARKET: DEPLOYMENT/CONNECTIVITY FOOTPRINT
  • TABLE 291 DIAGNOSTIC ECG MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 292 DIAGNOSTIC ECG MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS
  • TABLE 293 DIAGNOSTIC ECG MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MARCH 2025
  • TABLE 294 DIAGNOSTIC ECG MARKET: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 295 DIAGNOSTIC ECG MARKET: EXPANSIONS, JANUARY 2022-MARCH 2025
  • TABLE 296 DIAGNOSTIC ECG MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
  • TABLE 297 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 298 KONINKLIJKE PHILIPS N. V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 299 KONINKLIJKE PHILIPS N. V.: PRODUCT/SERVICE LAUNCHES, JANUARY 2022-APRIL 2025
  • TABLE 300 KONINKLIJKE PHILIPS N. V.: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 301 KONINKLIJKE PHILIPS N. V.: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 302 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 303 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 304 GE HEALTHCARE: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 305 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 306 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 307 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 308 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
  • TABLE 309 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 310 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 311 ABBOTT: PRODUCTS OFFERED
  • TABLE 312 ABBOTT: PRODUCT LAUNCHES, JANUARY 2022-APRIL 2025
  • TABLE 313 BAXTER: COMPANY OVERVIEW
  • TABLE 314 BAXTER: PRODUCTS OFFERED
  • TABLE 315 FUKUDA DENSHI: COMPANY OVERVIEW
  • TABLE 316 FUKUDA DENSHI: PRODUCTS OFFERED
  • TABLE 317 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 318 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
  • TABLE 319 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 320 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
  • TABLE 321 OSI SYSTEMS, INC: COMPANY OVERVIEW
  • TABLE 322 OSI SYSTEMS, INC.: PRODUCTS OFFERED
  • TABLE 323 OSI SYSTEMS, INC.: EXPANSIONS, JANUARY 2022-APRIL 2025
  • TABLE 324 BITTIUM: COMPANY OVERVIEW
  • TABLE 325 BITTIUM: PRODUCTS OFFERED
  • TABLE 326 BITTIUM: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 327 IRHYTHM TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 328 IRHYTHM TECHNOLOGIES, INC.: PRODUCTS OFFERED
  • TABLE 329 IRHYTHM TECHNOLOGIES, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-APRIL 2025
  • TABLE 330 IRHYTHM TECHNOLOGIES, INC.: DEALS, JANUARY 2022-APRIL 2025
  • TABLE 331 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW
  • TABLE 332 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED
  • TABLE 333 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-APRIL 2025
  • TABLE 334 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 335 MIDMARK CORPORATION: COMPANY OVERVIEW
  • TABLE 336 MIDMARK CORPORATION: PRODUCTS OFFERED
  • TABLE 337 MIDMARK CORPORATION: PRODUCT LAUNCH, JANUARY 2022-APRIL 2025
  • TABLE 338 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 339 BPL MEDICAL TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 340 BPL MEDICAL TECHNOLOGIES: EXPANSIONS, JANUARY 2022-APRIL 2025
  • TABLE 341 BPL MEDICAL TECHNOLOGIES: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 342 SCHILLER: COMPANY OVERVIEW
  • TABLE 343 SCHILLER: PRODUCTS OFFERED
  • TABLE 344 SCHILLER: PRODUCT LAUNCH, JANUARY 2022-APRIL 2025
  • TABLE 345 SCHILLER: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
  • TABLE 346 ACS DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 347 ACS DIAGNOSTICS: PRODUCTS OFFERED
  • TABLE 348 ALLENGERS: COMPANY OVERVIEW
  • TABLE 349 ALLENGERS: PRODUCTS OFFERED
  • TABLE 350 BIONET CO., LTD.: COMPANY OVERVIEW
  • TABLE 351 BIONET CO., LTD.: PRODUCTS OFFERED
  • TABLE 352 BIONET CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025

List of Figures

  • FIGURE 1 DIAGNOSTIC ECG MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE
  • FIGURE 2 DIAGNOSTIC ECG MARKET: YEARS CONSIDERED
  • FIGURE 3 DIAGNOSTIC ECG MARKET: RESEARCH DESIGN
  • FIGURE 4 DIAGNOSTIC ECG MARKET: KEY PRIMARY SOURCES
  • FIGURE 5 DIAGNOSTIC ECG MARKET: INSIGHTS FROM PRIMARIES
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 7 BREAKDOWN OF PRIMARIES, BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 8 DIAGNOSTIC ECG MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2024)
  • FIGURE 9 DIAGNOSTIC ECG: MARKET SIZE ESTIMATION
  • FIGURE 10 TOP-DOWN APPROACH
  • FIGURE 11 BOTTOM-UP APPROACH
  • FIGURE 12 DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2025 VS. 2032 (USD MILLION)
  • FIGURE 14 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2025 VS. 2032 (USD MILLION)
  • FIGURE 15 DIAGNOSTIC ECG MARKET, BY TYPE, 2025 VS. 2032 (USD MILLION)
  • FIGURE 16 DIAGNOSTIC ECG MARKET, BY DEPLOYMENT/CONNECTIVITY, 2025 VS. 2032 (USD MILLION)
  • FIGURE 17 DIAGNOSTIC ECG MARKET, BY END USER, 2025 VS. 2032 (USD MILLION)
  • FIGURE 18 GEOGRAPHICAL SNAPSHOT OF DIAGNOSTIC ECG MARKET
  • FIGURE 19 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES GLOBALLY TO DRIVE MARKET GROWTH
  • FIGURE 20 DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN DIAGNOSTIC ECG MARKET IN 2024
  • FIGURE 21 RESTING ECG DEVICES TO CAPTURE LARGEST SHARE OF DIAGNOSTIC ECG DEVICES MARKET IN 2025
  • FIGURE 22 12-LEAD ECG DEVICES SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2032
  • FIGURE 23 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT TO DOMINATE MARKET IN 2032
  • FIGURE 24 CHINA TO REGISTER HIGHEST GROWTH IN DIAGNOSTIC ECG MARKET FROM 2025 TO 2032
  • FIGURE 25 DIAGNOSTIC ECG MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 DIAGNOSTIC ECG MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 27 DIAGNOSTIC ECG MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014-MAY 2025)
  • FIGURE 28 TOP APPLICANT COUNTRIES/REGIONS FOR DIAGNOSTIC ECG PATENTS (JANUARY 2014-MAY 2025)
  • FIGURE 29 AVERAGE SELLING PRICE FOR RESTING ECG, BY KEY PLAYER, 2024
  • FIGURE 30 AVERAGE SELLING PRICE FOR STRESS ECG, BY KEY PLAYER, 2024
  • FIGURE 31 AVERAGE SELLING PRICE OF HOLTER MONITORS, BY KEY PLAYER, 2024
  • FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIAGNOSTIC ECG PRODUCTS
  • FIGURE 33 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS
  • FIGURE 34 DIAGNOSTIC ECG MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 35 DIAGNOSTIC ECG MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 36 DIAGNOSTIC ECG MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 37 AI USE CASES
  • FIGURE 38 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 39 DIAGNOSTIC ECG MARKET: INVESTMENT AND FUNDING SCENARIO, 2020-2024
  • FIGURE 40 DIAGNOSTIC ECG MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 41 NORTH AMERICA: DIAGNOSTIC ECG MARKET SNAPSHOT
  • FIGURE 42 ASIA PACIFIC: DIAGNOSTIC ECG MARKET SNAPSHOT
  • FIGURE 43 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS IN DIAGNOSTIC ECG MARKET (2022-2024)
  • FIGURE 44 DIAGNOSTIC ECG MARKET SHARE ANALYSIS, 2024
  • FIGURE 45 RANKING OF KEY PLAYERS IN DIAGNOSTIC ECG MARKET, 2024
  • FIGURE 46 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 47 DIAGNOSTIC ECG MARKET: COMPANY FOOTPRINT
  • FIGURE 48 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 49 DIAGNOSTIC ECG MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 50 EV/EBITDA OF KEY VENDORS
  • FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 52 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT, 2024
  • FIGURE 53 GE HEALTHCARE: COMPANY SNAPSHOT, 2024
  • FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT (2024)
  • FIGURE 55 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 56 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024)
  • FIGURE 57 BAXTER: COMPANY SNAPSHOT, 2024
  • FIGURE 58 FUKUDA DENSHI: COMPANY SNAPSHOT, 2024
  • FIGURE 59 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT, 2024
  • FIGURE 60 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT, 2024
  • FIGURE 61 OSI SYSTEMS, INC.: COMPANY SNAPSHOT, 2024
  • FIGURE 62 BITTIUM: COMPANY SNAPSHOT, 2024
  • FIGURE 63 IRHYTHM TECHNOLOGIES, INC.: COMPANY SNAPSHOT, 2024
  • FIGURE 64 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT, 2024